rfhg_69979.1

Basic information about the TSS

---

TSS ID: rfhg_69979.1 Species: human Chr: chr5		Start: 91374960 End: 91374981 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000505631.1:-363 GeneID: 57561 HGNC/MGI_ID: HGNC:29263 UniProt_ID: Nearer transcript ids and distances:

Gene_name: arrestin domain containing 3 Gene_symbol: ARRDC3 Gene_synonyms: KIAA1376 TLIMP Gene_source: HGNC:29263

TATA-Box annotation

---

Distance to TSS:	5127
Nearest PromoterID:	NM_001329671
Entrez ID:	57561
Nearest Unigene:	Hs.24684
Nearest Refseq:	NM_020801
Nearest Ensembl:	ENSG00000113369
Gene Name:	arrestin domain containing 3
Gene Alias:	TLIMP
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.545455
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARRDC3 p2@ARRDC3 p3@ARRDC3 p4@ARRDC3 p5@ARRDC3 p7@ARRDC3
Sample		p1@ARRDC3	p2@ARRDC3	p3@ARRDC3	p4@ARRDC3	p5@ARRDC3	p7@ARRDC3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.84	1.17	0.00	0.78	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	8.70	1.21	0.00	0.81	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	8.10	1.54	0.00	0.39	0.58	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	3.74	0.62	0.00	1.04	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.85	1.12	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.40	1.74	0.00	0.19	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6.10	1.96	0.00	0.22	0.65	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.06	0.73	0.00	2.18	0.00	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	4.92	0.21	0.21	0.64	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	29.56	5.22	1.16	1.16	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.06	2.83	0.00	1.21	0.00	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	30.08	2.03	0.00	1.22	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	32.88	2.74	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	42.85	2.86	1.05	0.75	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	37.98	2.63	1.10	0.22	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	33.70	2.51	0.50	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.76	1.75	0.22	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.73	2.53	1.27	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.19	3.73	0.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	33.55	2.26	1.05	0.30	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	36.09	3.21	0.27	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.73	3.28	0.69	1.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.21	2.07	1.16	0.52	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	26.21	3.15	0.49	0.73	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.77	2.06	0.26	0.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	20.89	3.48	0.32	0.63	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	19.23	4.40	2.20	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.03	0.94	0.24	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.73	1.62	0.00	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.48	0.90	0.36	0.36	0.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.42	0.42	0.00	0.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	9.57	0.98	0.20	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.60	0.63	0.42	0.21	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.85	1.65	0.16	0.16	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	10.10	1.31	0.00	0.19	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.01	0.38	0.38	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.06	0.82	0.61	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	9.87	1.21	0.20	0.00	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.86	0.81	0.27	0.81	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.44	1.20	0.00	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.82	1.41	0.00	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.81	1.17	0.44	0.29	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	13.92	1.05	0.00	0.42	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.46	0.87	0.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.46	1.41	0.20	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.19	1.63	0.23	0.23	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.52	0.72	0.24	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.82	0.89	0.30	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	17.47	1.20	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.98	0.81	0.20	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.60	1.43	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.01	2.00	0.44	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	181.90	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.94	0.35	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	7.55	0.84	1.68	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.53	2.30	1.38	1.84	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.08	0.65	0.00	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.07	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.83	1.26	0.31	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	0.00	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.97	0.00	0.56	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	15.92	2.39	0.80	0.00	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	9.51	1.02	1.02	0.00	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.75	0.97	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.39	0.35	0.35	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	96.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	55.28	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.39	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.45	1.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.16	0.47	0.47	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.62	0.33	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.88	0.93	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	4.28	0.92	0.00	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	15.36	2.53	1.11	0.00	0.16	0.00
Adipocyte - breast, donor2	11327-117E4	9.63	2.09	0.32	0.00	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	23.03	2.42	0.89	0.00	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	14.95	2.24	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	15.41	1.00	0.67	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	16.59	3.83	1.28	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	17.59	0.00	0.00	0.00	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	1.35	1.81	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.77	1.39	0.52	0.35	0.52	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	56.52	3.91	0.98	0.00	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	59.97	3.86	0.77	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	32.06	2.23	0.00	0.28	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	46.44	2.35	0.59	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	45.61	4.18	1.21	0.00	0.00	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	3.55	0.65	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	8.53	0.53	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	8.35	1.67	0.56	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	1.66	0.00	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.83	1.26	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	15.71	1.31	0.65	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	11.27	2.13	0.91	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	19.45	0.66	1.10	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.53	0.00	0.00	0.36	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	17.97	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.29	0.18	0.18	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	9.25	0.62	0.41	0.62	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	53.67	9.73	2.29	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	54.61	6.37	1.22	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	2.70	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	18.67	4.78	1.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.03	5.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	3.79	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.88	2.64	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.65	2.92	0.00	0.32	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	1.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	1.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.46	5.27	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	3.63	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	2.51	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	43.66	2.47	1.15	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	32.76	2.73	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	32.27	3.02	0.30	0.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	22.50	4.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.62	6.42	0.19	0.00	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	18.98	6.95	1.60	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	3.90	1.95	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.56	4.98	1.00	0.17	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	3.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	21.10	3.95	0.69	0.00	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	23.79	2.91	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	20.87	2.66	0.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	12.11	4.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	2.28	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.95	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	20.39	3.61	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	16.42	2.82	0.47	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	12.22	2.89	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	12.84	4.99	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	9.36	5.26	0.00	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.35	1.20	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	13.07	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.19	4.07	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	17.32	3.06	0.00	0.25	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.17	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	12.51	2.16	0.86	0.00	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.99	2.75	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.11	2.32	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	26.45	4.72	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.61	3.56	1.36	0.00	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	38.03	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.80	3.43	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.07	6.62	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	5.83	0.73	1.46	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.30	4.37	0.46	0.23	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	12.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	27.97	3.56	0.76	0.00	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.39	3.72	0.62	0.21	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.34	3.06	0.92	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	19.12	7.17	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	21.73	5.10	0.44	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	6.10	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	3.88	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	24.89	5.30	0.53	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	24.71	3.63	0.00	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	27.51	0.61	0.86	0.49	0.00	0.37
Astrocyte - cerebellum, donor2	11580-120F5	15.92	1.03	0.68	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	11.75	0.84	0.21	0.63	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	59.26	6.27	0.35	1.05	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	44.16	4.85	0.49	0.49	0.32	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	37.59	3.43	0.45	0.60	0.15	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	13.99	1.61	0.23	1.49	2.41	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.40	1.50	0.13	0.88	1.63	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.65	0.91	0.23	0.91	1.14	0.11
Basophils, donor1	12241-129G9	189.61	7.32	3.40	7.32	4.45	0.00
Basophils, donor2	12242-129H1	615.16	27.42	14.07	21.65	13.71	1.44
Basophils, donor3	12243-129H2	275.03	11.17	5.88	3.23	4.41	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	11.21	0.22	0.22	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.46	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.14	0.63	0.00	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	3.95	0.00	0.00	0.00	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	24.64	1.15	0.46	0.46	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	32.75	4.50	0.72	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	117.17	9.89	1.24	1.75	0.41	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	87.80	5.82	1.63	0.93	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	77.07	3.84	2.24	1.92	0.96	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	448.59	33.81	5.64	3.38	6.20	2.25
CD14+ Monocytes, donor2	11305-117B9	277.29	28.21	6.68	6.68	6.12	2.41
CD14+ Monocytes, donor3	11381-118B4	227.22	15.81	2.63	5.71	5.27	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	157.09	13.30	3.40	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	147.08	10.61	1.90	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	198.89	7.56	2.63	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	359.93	36.28	5.93	1.88	0.43	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	303.25	19.01	4.83	1.81	0.30	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	347.76	18.95	5.92	0.71	0.71	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	161.04	13.73	2.18	1.51	0.33	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	140.49	9.66	2.21	1.66	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	122.72	10.41	1.98	1.98	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	67.16	7.24	1.37	2.35	0.39	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	91.87	6.05	2.31	1.42	1.07	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	116.00	5.22	3.05	1.09	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	76.79	6.32	1.17	2.11	1.40	0.70
CD14+ monocytes - treated with Candida, donor2	11878-125C6	86.60	5.28	1.06	1.06	0.53	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	85.42	9.98	3.33	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	249.01	29.90	5.50	2.53	1.04	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	209.13	14.77	4.99	2.39	0.80	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	313.76	22.07	9.16	2.71	0.21	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	88.31	12.35	1.60	1.37	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	119.44	5.43	2.04	1.81	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	74.20	6.11	0.44	0.87	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	207.12	12.91	4.57	2.42	0.54	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	236.57	18.32	3.84	1.74	1.40	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	247.44	12.20	2.10	0.42	0.84	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	197.86	27.19	3.31	1.65	1.10	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	185.64	8.45	2.82	2.11	1.41	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	192.16	9.65	2.63	2.63	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	95.91	15.17	1.57	0.70	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	98.12	12.64	1.12	1.86	0.74	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	142.91	6.90	3.23	1.94	0.86	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	190.00	22.93	3.69	1.64	1.64	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	217.66	8.34	3.01	3.01	0.70	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	277.00	13.22	5.34	2.32	1.62	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	183.31	15.48	6.97	0.22	0.65	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	129.59	13.40	3.93	0.46	1.39	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	170.91	9.96	3.90	0.87	0.65	1.08
CD14+CD16- Monocytes, donor1	11788-124B6	241.06	17.91	5.92	1.09	1.71	1.25
CD14+CD16- Monocytes, donor2	11799-124C8	221.27	22.70	5.94	1.92	0.17	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	341.81	15.16	11.59	1.78	1.78	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	245.48	15.06	5.61	0.26	0.26	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	217.15	20.20	2.63	0.44	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	302.13	18.53	5.90	0.63	0.42	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	355.65	8.13	6.10	0.00	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	308.48	10.85	2.03	2.03	7.46	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	416.31	9.32	6.21	7.25	12.43	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	206.82	19.19	2.67	1.60	0.00	3.20
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	325.39	20.37	5.90	2.68	5.36	5.36
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	330.61	2.11	4.21	4.91	3.51	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	320.80	14.12	5.49	3.14	4.71	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	375.71	6.59	9.23	3.95	7.91	1.32
CD19+ B Cells, donor1	11544-120B5	176.71	23.84	0.00	4.11	5.75	1.64
CD19+ B Cells, donor2	11624-122B4	105.19	10.16	0.00	2.90	5.08	0.73
CD19+ B Cells, donor3	11705-123B4	142.87	9.59	0.50	8.08	5.05	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	155.16	14.95	3.64	2.02	3.64	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	123.84	12.78	2.80	3.99	3.20	0.40
CD34+ Progenitors, donor1	11545-120B6	114.46	0.00	3.01	1.00	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	171.91	2.81	6.18	0.56	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	131.14	14.28	1.50	1.50	1.50	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	130.55	11.95	2.71	1.35	0.23	1.35
CD4+ T Cells, donor1	11225-116C1	417.40	24.64	3.57	10.71	6.07	0.71
CD4+ T Cells, donor2	11306-117C1	265.15	36.13	1.84	9.80	7.35	1.22
CD4+ T Cells, donor3	11382-118B5	419.06	15.25	5.49	7.32	5.79	7.62
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	282.55	5.87	6.38	1.53	2.55	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	321.62	11.68	6.29	2.02	1.80	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	273.38	9.49	4.60	3.74	1.44	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	839.62	42.19	9.01	6.64	5.69	4.27
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	933.39	47.06	11.94	5.62	7.02	9.13
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1091.05	69.22	13.18	26.37	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	163.16	6.21	3.18	1.30	1.01	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	138.28	12.88	3.05	0.34	1.69	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	158.14	13.06	3.55	0.64	0.64	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	599.38	55.59	11.21	1.34	2.69	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	670.13	53.81	7.34	2.45	3.84	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	967.52	43.12	12.76	7.92	3.96	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	231.48	7.59	5.48	0.84	1.26	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	117.18	11.64	2.91	1.87	1.66	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	148.69	7.35	3.68	1.00	0.33	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	860.67	45.14	13.32	4.62	4.62	6.25
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	940.06	38.05	12.86	4.82	3.22	6.97
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	749.57	41.24	3.59	5.38	3.59	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	149.83	5.75	1.30	1.67	1.30	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	144.05	4.77	2.38	0.22	0.65	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	229.49	6.72	4.20	1.26	1.47	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	436.84	14.66	6.57	4.04	3.54	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	567.13	23.83	5.63	3.90	5.63	6.93
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	794.05	40.53	11.77	8.72	6.97	4.36
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	398.86	22.27	4.95	2.47	3.46	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	271.42	12.92	0.92	2.77	4.62	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	330.81	18.15	4.19	12.56	4.19	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	271.67	10.52	1.66	1.66	1.11	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	381.09	15.71	4.17	0.74	2.70	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	409.64	15.40	0.00	4.62	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	381.40	25.07	3.94	1.79	3.22	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	385.03	23.54	0.00	6.92	4.15	2.77
CD8+ T Cells, donor1	11226-116C2	502.22	22.92	3.93	24.55	13.75	2.29
CD8+ T Cells, donor2	11307-117C2	340.52	24.78	4.13	16.14	15.77	3.75
CD8+ T Cells, donor3	11383-118B6	442.87	18.94	2.52	21.46	20.20	4.29
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.67	0.92	0.00	0.46	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.59	0.24	0.00	0.24	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.02	0.55	0.00	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	4.50	0.90	0.00	0.30	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.64	0.48	0.00	0.24	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	3.41	0.68	0.00	0.23	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.56	0.65	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.47	0.53	0.00	0.26	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.22	0.23	0.00	0.47	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.13	1.21	0.30	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	0.87	0.00	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.19	0.00	0.27	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	11.38	0.44	0.44	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	14.12	0.46	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	0.75	0.00	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.88	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	3.74	1.15	0.00	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	2.12	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.39	0.32	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	4.61	0.62	0.00	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.45	0.64	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	7.27	0.38	0.00	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.67	1.58	0.00	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	4.54	0.76	0.00	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	39.34	2.41	0.00	2.41	1.61	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.26	8.39	0.00	2.10	2.80	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	3.01	1.00	0.00	1.00	5.01
Cardiac Myocyte, donor1	11525-119I4	60.32	5.48	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	43.48	6.92	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	75.87	7.58	1.68	0.00	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	84.59	7.97	2.08	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	100.22	6.75	2.49	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	57.57	16.61	1.59	0.00	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	152.19	3.58	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	59.85	2.43	1.62	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.67	5.74	1.03	0.69	0.23	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	24.37	3.63	0.43	0.64	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	40.09	3.72	0.88	0.88	0.53	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	145.62	6.60	3.12	1.38	0.83	0.55
Corneal Epithelial Cells, donor1	11526-119I5	9.66	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	17.06	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	10.23	0.51	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	50.52	3.80	0.33	0.00	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	49.83	4.42	1.58	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	28.08	1.30	0.22	0.43	0.11	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	55.35	3.76	0.68	0.68	1.71	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	41.13	1.31	2.61	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.97	0.48	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	60.87	3.17	0.50	0.33	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	16.43	0.59	1.76	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	41.29	1.70	0.00	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	27.92	0.79	0.39	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	14.83	0.00	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	20.70	2.82	0.24	0.24	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	21.74	0.53	0.35	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	75.36	8.87	1.99	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	99.19	5.78	1.83	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	133.34	5.64	3.66	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	13.37	1.19	0.00	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	23.95	1.56	0.00	0.00	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	9.36	1.28	0.14	0.14	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	48.01	4.80	0.80	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	15.72	0.00	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	60.63	7.33	1.12	0.12	0.12	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	26.51	1.74	0.65	0.22	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	25.89	0.73	0.49	0.24	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	19.34	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	32.13	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.71	0.79	0.63	0.00	0.00	0.16
Eosinophils, donor1	12244-129H3	106.73	15.25	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	704.66	19.80	29.70	1.65	4.95	0.00
Eosinophils, donor3	12246-129H5	613.49	14.27	14.27	0.00	3.57	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	51.31	4.11	1.64	0.00	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.47	0.88	0.66	0.00	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	37.70	5.42	0.87	0.43	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	59.55	9.82	1.46	0.85	0.36	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	117.37	6.00	5.05	0.82	0.68	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.11	4.85	0.74	0.63	0.42	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	97.23	6.06	2.11	1.32	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	62.12	7.64	0.66	1.99	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	57.61	3.63	3.63	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	0.76	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.56	1.10	0.47	0.00	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	64.56	2.42	1.82	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	46.45	2.66	1.14	0.25	0.00	0.25
Fibroblast - Cardiac, donor6	11460-119B2	38.96	3.18	0.91	0.15	0.15	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.40	0.54	0.27	0.40	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	62.56	6.47	1.73	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	4.39	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	15.68	0.69	0.23	1.15	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	35.45	1.70	0.85	0.51	0.34	0.51
Fibroblast - Dermal, donor1	11269-116G9	19.96	0.70	0.00	0.00	0.00	0.47
Fibroblast - Dermal, donor2	11346-117G5	23.11	1.89	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	22.24	3.38	0.60	0.00	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	40.92	3.39	1.02	0.68	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	24.25	4.01	0.35	0.35	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	29.40	2.27	0.32	0.16	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	27.90	5.83	2.08	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	86.98	4.19	1.57	0.26	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	21.74	5.27	0.66	0.40	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	28.62	1.55	0.58	0.77	0.19	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	96.62	7.27	2.08	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	44.93	5.99	0.88	0.00	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	56.43	4.37	1.40	0.31	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	51.66	5.95	1.35	0.54	0.41	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	37.76	0.00	1.76	0.35	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	65.08	4.97	2.49	0.44	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	79.77	5.18	3.14	0.00	0.00	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	56.27	1.97	1.10	0.44	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	50.77	2.79	1.91	0.73	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	19.03	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	1.49	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	9.92	1.90	0.42	0.00	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	6.66	0.00	0.83	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	9.79	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	0.00	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	18.27	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.38	3.69	1.55	0.00	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.58	1.52	1.06	0.00	0.00	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	25.70	1.53	0.31	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	39.69	3.05	1.14	0.00	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	41.85	7.56	2.43	0.27	0.00	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	55.32	3.94	0.70	0.00	0.35	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.56	6.52	0.55	0.00	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.11	0.00	0.20	0.00	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.63	2.77	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	52.19	2.18	0.99	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	80.28	7.99	1.78	0.18	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	86.52	8.08	2.17	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	78.22	3.01	2.41	1.50	0.30	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	81.61	6.48	1.94	0.00	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	86.05	5.31	3.04	0.51	0.76	0.25
Fibroblast - skin normal, donor1	11553-120C5	45.94	5.25	1.15	0.33	0.00	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	105.87	4.21	2.01	0.80	0.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	78.06	4.32	2.11	0.40	0.10	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	122.41	4.53	2.72	0.00	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	111.84	10.69	2.98	0.33	0.41	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	82.06	7.69	2.05	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	112.00	2.96	4.60	2.63	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	52.94	4.15	1.60	0.11	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	24.12	3.88	0.51	0.00	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	33.56	3.61	1.25	0.16	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	110.80	22.16	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	107.20	0.87	1.74	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	8.84	0.69	0.52	0.17	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	10.93	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.64	0.77	0.26	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.01	0.77	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.12	1.91	0.00	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	163.17	19.11	3.42	11.98	1.43	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	179.24	41.64	1.38	9.93	2.21	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	275.59	47.95	4.11	19.18	5.94	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	137.30	16.44	1.19	6.93	0.99	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	153.05	22.47	2.11	7.14	1.85	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	300.38	30.66	4.24	26.42	12.39	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	136.20	39.80	1.77	11.50	4.42	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	73.91	6.50	1.41	0.85	0.57	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.15	4.56	0.62	0.49	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	39.49	5.10	1.61	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.39	2.85	0.99	0.37	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.44	1.80	0.97	0.14	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.13	3.66	0.61	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	41.53	9.36	1.60	0.68	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	50.08	3.61	0.37	0.00	0.12	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	63.82	3.50	1.09	0.44	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.39	9.16	0.89	0.59	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	35.45	3.18	0.48	0.00	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	28.15	3.57	0.22	0.22	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	47.59	7.86	0.40	0.60	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.88	2.21	1.19	0.34	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	52.05	4.26	0.98	0.44	0.18	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.98	2.91	1.04	0.31	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	71.04	2.05	0.85	0.51	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.94	1.88	0.55	0.11	0.11	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.75	3.99	0.33	0.42	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.45	4.08	0.20	0.61	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	50.13	7.43	0.83	0.62	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	44.04	4.15	0.92	0.58	0.35	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.19	5.00	0.83	1.17	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	47.83	6.83	0.66	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	49.69	2.46	0.61	0.49	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	33.23	2.92	0.32	0.49	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	33.35	5.45	1.28	0.00	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.72	2.94	0.85	0.19	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	39.86	4.90	0.32	0.63	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	52.00	6.99	0.91	1.22	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	57.08	5.44	0.73	0.31	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.28	4.61	0.22	0.44	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	45.17	6.17	0.28	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	41.20	1.11	0.74	0.19	0.37	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.93	2.41	0.27	0.53	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	25.40	3.52	0.92	0.15	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	21.24	0.78	0.13	0.00	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.89	1.08	0.27	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	52.36	7.19	1.84	0.00	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	48.69	7.02	0.66	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	2.98	1.98	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.26	5.28	0.53	0.13	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	37.33	3.03	0.81	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	54.64	3.30	1.52	0.51	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	53.75	4.18	0.80	0.40	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.90	2.47	0.46	1.39	0.31	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	42.55	1.64	0.82	1.43	0.00	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	39.12	1.25	0.31	0.31	0.63	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	31.36	1.70	0.28	0.85	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	39.20	4.15	1.38	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	47.02	9.90	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	57.25	5.42	0.39	3.48	0.00	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	40.11	17.65	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	5.22	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.66	5.53	0.65	1.95	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	44.89	9.06	0.82	0.82	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.81	8.39	0.84	1.40	0.00	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	48.70	6.86	0.98	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	35.23	8.39	0.84	3.36	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	58.84	7.00	2.23	1.59	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	38.38	8.15	1.02	1.36	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	60.56	6.26	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	52.69	10.88	0.57	2.86	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.37	7.70	1.18	1.18	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	64.38	6.78	0.00	3.39	1.69	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	62.13	8.70	0.83	1.66	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	53.16	11.05	0.46	2.76	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	10.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	78.42	15.76	1.15	3.46	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	62.91	5.22	0.65	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	83.60	6.69	2.01	1.34	2.01	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	69.35	7.71	0.77	5.01	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	52.38	7.87	0.34	2.74	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	109.33	14.91	2.48	4.97	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	110.41	18.87	0.00	3.30	1.89	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	68.80	15.09	1.21	1.81	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	113.94	6.61	1.02	2.03	0.51	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	108.88	14.76	1.99	3.59	0.40	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	122.85	13.32	0.49	8.39	1.48	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	84.99	17.71	0.00	7.08	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	79.35	15.75	1.17	4.67	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	154.93	18.87	1.76	3.95	3.51	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	46.62	12.72	0.00	5.93	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	39.99	8.95	0.60	0.60	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	63.08	11.65	0.49	1.46	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	39.95	1.14	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	26.20	4.16	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	16.87	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	35.20	7.61	0.32	0.00	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.14	7.52	0.84	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	32.14	5.80	0.93	0.35	0.23	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.76	5.06	1.18	0.68	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.71	3.41	0.68	0.23	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.99	7.65	0.55	0.22	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	40.19	6.45	0.64	0.21	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.63	4.52	1.29	0.65	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.94	2.24	0.25	0.50	0.37	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	19.39	1.20	0.34	1.54	0.17	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.98	1.60	0.00	0.64	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	18.47	0.00	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.49	0.00	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	5.29	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	14.46	0.00	1.06	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.00	0.00	0.73	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	39.16	9.09	1.40	0.35	0.00	0.00
Hepatocyte, donor1	11523-119I2	43.58	6.05	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	26.93	8.62	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	63.19	6.14	3.07	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	98.56	9.79	1.96	3.92	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	132.66	14.51	2.62	0.35	0.70	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	101.53	10.15	1.78	0.14	0.00	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	44.30	0.00	0.00	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	0.00	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	74.32	0.00	2.56	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	41.14	0.00	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	0.00	1.62	1.62	0.00	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	25.01	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	33.09	0.00	0.00	0.00	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	18.85	1.11	0.00	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.71	0.00	0.00	1.26	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	21.65	0.00	1.55	1.55	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	16.80	0.00	1.29	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	27.37	0.00	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	14.67	0.00	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	15.95	0.00	0.84	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.86	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	10.16	0.92	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.66	0.47	0.47	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.95	0.91	0.00	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	30.49	1.27	1.27	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	32.52	0.00	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	23.69	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	35.70	0.00	0.71	0.71	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	13.89	0.31	0.62	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.74	0.00	0.00	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	35.75	0.00	1.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	0.00	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	0.00	0.00	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	32.00	0.00	0.00	1.07	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	41.56	1.39	1.39	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	0.00	0.00	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	0.00	0.92	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	27.23	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	0.00	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	0.00	0.00	1.06	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	6.45	0.57	0.08	0.08	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	13.47	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	15.24	1.99	0.09	0.00	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	26.45	3.86	0.23	0.23	0.00	0.00
Keratocytes, donor1	11527-119I6	13.41	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	3.52	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	22.33	2.37	0.99	0.00	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	24.18	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	21.57	5.39	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	52.25	7.84	0.81	0.23	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	62.26	2.42	1.31	0.40	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	45.77	2.61	0.95	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	25.67	5.30	0.84	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	54.78	12.28	1.42	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	28.50	4.84	0.54	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	20.17	1.26	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.04	4.53	0.32	0.00	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	36.52	7.80	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	18.71	2.78	1.01	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	27.16	4.79	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	38.37	5.54	0.79	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	43.04	8.53	1.16	0.19	0.19	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.44	2.22	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.73	11.50	2.79	0.00	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	33.63	5.72	0.95	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.78	4.26	0.41	0.00	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.42	8.31	1.85	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.30	2.18	0.00	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	24.34	2.93	0.37	0.00	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	40.15	7.57	0.99	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.48	3.22	0.59	0.00	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.41	1.99	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	55.77	12.61	4.36	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	55.74	7.54	1.35	0.27	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	39.51	7.57	1.06	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	41.99	5.18	0.52	1.04	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	67.84	15.91	1.88	0.42	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	32.33	5.56	1.05	0.30	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	28.89	8.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	41.96	7.15	0.94	0.56	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.54	2.12	0.74	0.42	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	29.07	6.78	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	34.73	3.97	0.66	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.69	3.84	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	33.32	4.81	1.85	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	50.16	6.42	0.49	0.49	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.51	2.89	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	41.81	4.18	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	55.69	10.35	0.61	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.09	5.18	0.84	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.64	6.40	1.07	0.00	0.00	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	29.57	3.39	0.48	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.65	0.47	0.62	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	23.99	4.30	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.99	1.63	0.00	0.00	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.36	1.88	0.00	0.00	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.00	3.59	1.11	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.77	2.56	0.51	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.73	3.28	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	79.31	2.27	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	62.90	5.37	0.77	1.53	1.53	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	72.74	1.48	1.48	2.23	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	99.01	9.31	3.39	2.54	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	55.56	7.03	3.52	2.81	0.00	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	70.98	2.80	0.93	0.93	0.00	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	71.62	11.34	1.55	2.58	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	58.28	7.14	0.00	0.00	1.19	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	89.35	4.75	2.49	0.68	0.90	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	64.85	14.25	1.16	1.45	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	60.77	5.40	0.90	0.45	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	104.60	2.30	2.17	0.41	1.22	2.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	83.70	11.81	3.08	1.03	1.54	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.58	6.35	1.76	0.35	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	41.31	5.33	1.33	0.67	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	85.07	6.11	1.02	2.04	0.51	2.55
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	43.22	6.14	1.07	0.27	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	55.74	9.26	2.08	0.38	0.38	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	76.08	7.98	3.07	1.84	1.23	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	73.39	8.97	0.82	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	51.44	5.21	1.46	0.83	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	49.05	5.61	1.12	0.28	0.28	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	58.73	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	43.84	9.87	0.87	0.29	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	40.06	7.47	0.60	0.90	0.00	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	41.49	3.32	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	72.82	5.30	1.41	2.83	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	75.23	6.27	2.58	2.58	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	70.23	2.30	1.15	1.15	3.45	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	83.66	4.61	1.54	1.15	0.77	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	73.03	6.79	3.96	0.00	0.57	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	71.38	4.92	0.00	4.10	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	88.12	5.87	1.36	1.36	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	83.30	11.49	3.59	4.31	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	85.15	5.23	2.24	0.00	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	86.95	7.06	1.11	0.37	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	72.80	7.75	1.72	2.15	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	86.49	6.85	3.43	0.86	0.00	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	86.63	7.33	2.67	1.67	0.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	73.60	4.22	2.41	0.60	1.21	3.02
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	71.81	0.00	1.42	2.13	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	77.68	7.91	1.72	2.75	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	74.61	8.05	1.61	1.61	0.54	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	63.97	0.67	1.35	0.67	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	78.90	7.04	2.59	1.85	1.48	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	80.24	0.00	0.00	0.00	1.16	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	56.06	4.23	2.12	0.00	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	68.03	3.20	2.00	1.20	0.00	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	101.76	8.00	1.45	1.45	2.18	4.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	115.74	6.90	1.53	0.77	0.00	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	110.99	10.85	2.96	1.97	0.49	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	85.62	14.11	0.94	1.88	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	95.03	6.03	2.01	0.50	0.50	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	97.79	8.11	0.90	1.35	2.25	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	118.76	6.88	3.44	0.00	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	107.33	8.46	3.56	1.78	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	106.75	9.38	2.74	1.17	0.39	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	104.24	9.90	3.30	0.66	0.66	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	89.26	7.26	2.08	1.04	0.52	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	109.83	10.50	2.19	0.00	0.44	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	72.12	5.59	0.00	0.56	0.56	3.35
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	67.13	2.21	1.32	1.32	0.00	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	79.84	5.40	1.93	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	73.93	7.60	2.53	1.01	0.00	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	59.12	4.33	0.48	0.48	0.96	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	60.82	5.57	1.19	0.80	1.59	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	68.05	9.11	2.43	0.61	1.82	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	53.26	2.77	2.77	2.08	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	62.70	5.70	2.66	1.52	0.76	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	76.43	8.26	1.03	0.52	0.52	4.65
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	45.95	4.84	2.42	0.60	0.00	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	66.55	6.65	1.90	1.58	0.95	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	83.16	4.80	1.07	0.53	0.53	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	78.73	3.45	1.72	0.57	0.00	4.02
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	95.65	4.11	2.06	0.51	1.03	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	60.83	7.78	1.41	2.12	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	75.48	3.40	1.70	0.57	0.57	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	77.80	2.91	2.91	0.83	1.66	2.91
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	99.45	6.26	1.57	1.57	0.78	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	67.23	2.51	2.92	0.42	0.00	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	73.88	5.58	1.39	0.93	0.00	3.72
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	76.27	6.02	0.67	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	71.11	4.81	2.67	1.60	0.00	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	87.28	2.02	1.62	2.02	1.21	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	65.16	4.59	0.92	0.00	0.00	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	80.02	5.33	1.78	0.89	0.00	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	74.08	7.41	0.57	0.57	1.71	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	73.62	3.83	0.77	0.77	0.77	7.67
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	71.68	3.28	2.19	0.00	0.00	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	74.84	3.12	0.00	0.45	0.00	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	75.39	3.12	1.82	1.30	0.00	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	73.60	2.65	0.66	1.33	0.00	5.97
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	0.00	2.08	2.08	0.00	4.16
Macrophage - monocyte derived, donor1	11232-116C8	128.54	12.08	3.42	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	34.68	2.75	0.73	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	50.99	3.15	1.70	0.00	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	5.84	0.53	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.41	0.95	0.48	0.00	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	6.25	0.69	0.56	0.00	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	38.46	8.47	1.10	0.90	0.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	26.06	4.34	1.45	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.74	0.00	0.25	0.25	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	675.90	16.95	25.08	5.42	4.07	0.00
Mast cell, donor1	11563-120D6	166.43	13.63	3.46	0.65	0.65	0.11
Mast cell, donor2	11565-120D8	212.78	7.13	4.46	2.38	3.86	0.59
Mast cell, donor3	11566-120D9	518.91	16.43	9.23	9.23	12.83	2.48
Mast cell, donor4	11567-120E1	232.96	7.27	5.67	3.19	4.08	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	140.50	6.21	4.32	2.66	1.33	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	79.38	5.84	3.50	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	70.55	5.39	1.72	0.69	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	94.23	4.35	2.01	1.51	0.84	0.00
Melanocyte - dark, donor1	11502-119F8	45.87	5.97	0.90	0.10	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	39.11	7.61	0.00	0.69	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	17.17	1.52	0.22	0.00	0.07	0.07
Melanocyte - light, donor1	11274-116H5	11.28	0.47	0.00	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	9.55	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	13.88	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	8.54	0.73	0.31	0.10	0.10	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	4.30	0.54	0.27	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	21.16	2.14	0.00	0.00	0.00	0.00
Meningeal Cells, donor1	11493-119E8	11.17	0.25	0.25	0.50	0.00	0.00
Meningeal Cells, donor2	11573-120E7	18.05	0.44	0.00	0.44	0.00	0.44
Meningeal Cells, donor3	11654-122E7	23.23	2.61	0.65	0.00	0.00	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	63.02	13.40	2.57	0.00	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	21.54	1.91	0.40	0.10	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	0.00	2.63	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	12.20	2.87	1.44	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	38.33	3.39	1.06	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.59	3.02	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.94	0.66	0.44	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	12.42	0.73	0.00	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.91	0.00	1.02	0.20	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	88.09	6.65	2.22	0.28	0.00	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.29	0.00	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	50.79	7.11	0.66	0.26	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	16.32	1.48	0.00	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	14.89	4.61	1.06	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	40.65	7.19	0.31	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	3.63	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	13.52	2.12	0.53	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	13.51	0.50	1.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.42	1.16	0.29	0.00	0.07	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	32.75	2.71	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	22.67	0.59	1.18	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	54.24	2.17	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.43	3.53	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	160.92	15.77	4.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	57.72	1.86	1.86	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	163.79	19.71	4.67	0.20	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	62.56	8.32	0.79	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	115.04	19.47	7.08	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	87.01	17.10	3.04	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	117.78	22.28	4.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	0.00	1.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	71.83	9.54	3.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	73.26	14.05	0.50	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.23	3.80	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	3.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	46.74	6.68	1.15	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.72	1.68	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.35	0.82	0.61	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	42.69	4.51	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.45	0.44	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	26.06	3.50	0.66	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	25.55	1.90	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.18	0.88	0.29	0.00	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	38.92	3.36	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	13.61	0.00	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	59.57	7.01	0.50	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	88.02	12.70	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	0.00	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	123.22	14.38	4.71	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	12.53	0.70	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	30.94	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	88.55	15.38	2.39	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.82	0.00	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.72	3.55	0.36	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	86.97	12.91	3.93	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.70	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.82	0.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	57.92	7.84	2.41	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	32.56	2.92	0.83	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	71.11	6.46	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	51.22	2.28	2.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	33.99	0.83	0.97	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	56.49	9.59	0.78	0.26	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	33.03	0.86	1.72	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	44.57	1.60	1.60	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	72.44	4.19	1.50	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.27	0.99	0.71	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	49.69	9.24	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	63.69	2.65	2.65	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.41	0.00	0.38	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	88.36	15.34	1.14	0.57	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	66.37	5.16	1.23	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.29	5.21	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	62.63	6.47	1.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	71.50	3.17	2.31	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	116.22	7.01	4.12	0.41	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	52.71	3.57	1.49	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	15.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	108.72	26.73	7.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	98.24	13.80	2.30	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	35.77	9.47	1.05	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	28.47	1.78	0.40	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	25.15	3.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.54	2.63	1.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.44	2.13	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	66.16	3.73	2.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	45.68	7.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	87.58	10.26	2.93	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	9.33	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	2.67	0.00	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	20.20	7.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	11.38	1.69	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	144.37	1.36	0.00	9.53	1.36	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	28.61	0.00	2.54	1.27	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	21.06	1.62	0.81	3.24	0.81	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	86.09	6.04	0.00	13.59	3.02	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	616.70	5.71	0.00	11.42	5.71	28.55
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	809.09	26.10	13.05	26.10	6.52	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	180.59	9.50	4.75	0.00	9.50	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	276.08	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.54	2.59	0.00	0.43	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	27.70	6.27	2.09	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	19.36	2.00	0.00	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	45.82	0.76	0.19	1.33	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	55.85	6.38	4.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	13.60	0.00	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	84.53	9.19	1.84	1.84	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	51.90	2.09	2.93	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.94	0.23	0.70	0.23	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	27.83	0.54	1.35	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	91.87	4.84	2.31	1.05	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	111.35	22.27	11.13	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	50.63	1.49	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	57.92	3.25	2.44	1.62	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	47.83	1.36	1.13	0.00	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	25.80	0.33	1.31	0.16	0.65	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	97.32	6.38	3.46	0.73	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	58.35	2.12	1.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	63.03	2.40	2.40	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	111.91	4.59	2.95	0.98	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	43.10	1.30	1.95	0.65	0.65	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	79.55	2.82	3.00	0.18	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	78.06	1.41	2.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	57.46	1.38	2.30	0.92	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	53.02	2.89	1.61	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	225.90	15.52	6.21	5.17	2.41	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	106.19	12.64	5.06	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	63.94	2.23	1.78	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	40.22	1.27	2.12	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	69.31	0.95	1.90	0.71	0.95	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	35.20	0.00	0.86	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	63.19	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.66	0.33	1.33	1.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.40	0.90	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	27.38	1.59	0.40	0.00	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	36.22	2.79	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	38.59	0.76	0.76	0.76	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.29	0.98	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.17	0.00	0.44	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	33.02	1.81	1.81	0.00	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	32.63	0.00	1.76	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	35.90	1.33	0.66	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	57.54	0.00	1.49	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	20.67	0.38	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.08	1.81	1.21	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	54.15	3.54	2.43	0.44	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	26.43	0.68	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	35.77	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	40.85	1.22	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.63	0.63	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.44	0.91	0.61	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	0.79	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	89.56	6.80	2.27	2.27	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	268.07	50.58	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	41.49	4.72	0.50	0.50	0.50	0.00
Myoblast, donor2	11322-117D8	54.08	6.33	2.30	0.19	0.38	0.38
Myoblast, donor3	11398-118D3	53.48	3.03	1.35	0.67	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	105.66	6.57	1.17	1.90	0.44	0.15
Natural Killer Cells, donor1	11230-116C6	415.46	22.14	5.54	16.61	10.76	4.61
Natural Killer Cells, donor2	11311-117C6	336.54	27.74	4.82	15.08	9.65	3.32
Natural Killer Cells, donor3	11387-118C1	339.58	16.38	4.97	13.07	18.41	4.60
Neural stem cells, donor1	11275-116H6	97.63	4.36	2.90	0.73	0.36	0.36
Neural stem cells, donor2	11352-117H2	487.19	9.63	7.70	5.78	0.00	0.00
Neurons, donor1	11494-119E9	257.17	22.76	3.41	6.83	0.00	1.14
Neurons, donor2	11574-120E8	212.24	24.66	2.20	2.20	1.10	1.10
Neurons, donor3	11655-122E8	313.25	37.82	6.58	4.11	0.82	1.64
Neutrophils, donor1	11233-116C9	934.50	19.49	19.49	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	368.16	31.89	2.90	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	1151.44	11.61	23.21	1.22	0.00	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	81.93	9.62	1.42	0.36	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	40.70	13.35	0.98	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	29.08	3.21	1.00	0.00	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	91.13	15.55	3.44	0.14	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	84.53	9.55	3.04	0.58	0.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	55.28	8.74	1.14	0.45	0.34	0.00
Olfactory epithelial cells, donor4	11936-126A1	122.14	10.23	3.02	0.00	0.00	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	50.55	9.63	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	34.46	2.77	1.06	0.64	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	14.86	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	21.72	0.62	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	25.60	0.20	0.39	0.00	0.00	0.20
Osteoblast, donor2	11354-117H4	64.61	8.43	0.70	0.70	0.00	0.70
Osteoblast, donor3	11426-118G4	8.71	0.89	0.36	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	40.85	5.14	0.67	0.51	0.17	0.00
Pericytes, donor1	11491-119E6	11.68	0.00	0.33	0.22	0.22	0.00
Pericytes, donor2	11571-120E5	12.22	0.91	0.68	0.68	0.68	0.45
Pericytes, donor3	11652-122E5	12.82	0.81	1.02	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	40.46	5.88	1.02	0.11	0.34	0.00
Perineurial Cells, donor2	11579-120F4	72.69	6.44	1.38	0.28	0.18	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	221.21	9.24	1.59	1.59	1.91	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	138.84	16.90	2.20	2.45	2.94	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	83.47	4.66	0.91	0.65	1.16	0.26
Placental Epithelial Cells, donor1	11278-116H9	42.09	1.43	0.48	0.96	0.00	0.72
Placental Epithelial Cells, donor2	11355-117H5	11.09	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	9.23	0.98	0.20	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	4.11	0.63	0.32	0.00	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	21.38	0.75	0.56	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.84	1.31	1.31	0.39	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	14.86	1.13	0.45	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	19.50	2.56	1.28	0.11	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	24.88	1.31	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	16.90	2.01	0.29	0.00	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	3.94	0.00	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	30.71	0.61	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	28.33	2.48	1.06	0.18	0.71	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	26.90	3.75	0.17	0.51	0.51	0.17
Preadipocyte - visceral, donor1	11280-116I2	53.28	5.50	1.68	0.19	0.09	0.00
Preadipocyte - visceral, donor2	11357-117H7	30.37	4.14	1.38	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	40.86	5.12	1.57	0.00	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	107.41	9.96	1.51	1.36	0.45	0.15
Prostate Epithelial Cells, donor2	11331-117E8	18.55	2.57	0.95	0.00	0.00	0.14
Prostate Epithelial Cells, donor3	11404-118D9	22.11	2.63	0.61	0.31	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	45.79	6.15	1.37	0.46	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	38.73	5.38	0.72	0.00	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	23.88	3.13	0.42	0.21	0.00	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.22	1.09	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	45.40	5.68	0.62	0.14	0.00	0.28
Renal Epithelial Cells, donor1	11517-119H5	8.12	0.51	0.00	0.51	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	6.40	0.71	1.42	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	73.05	10.59	1.59	0.11	0.11	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	9.70	0.67	0.13	0.13	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	31.97	4.00	0.22	0.44	0.00	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	16.64	0.00	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.24	0.22	0.00	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.76	0.00	0.00	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	6.10	0.28	0.00	0.55	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.35	0.27	0.27	0.00	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.22	0.00	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.57	0.58	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	24.89	4.15	0.78	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	3.41	0.57	0.28	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	33.62	6.02	0.75	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	377.12	38.89	7.48	1.60	0.13	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	29.48	2.68	0.00	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	45.68	3.30	2.20	1.65	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	39.44	0.58	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	38.23	2.47	0.39	0.26	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	22.34	1.69	0.60	0.30	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.22	3.12	0.67	0.33	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	55.70	5.33	0.50	0.62	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	28.09	2.68	0.35	0.58	0.35	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	26.58	3.24	0.23	2.08	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	22.86	2.74	0.41	0.41	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	25.57	1.36	0.30	0.61	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	21.86	2.33	0.36	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	22.38	2.73	0.29	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	28.65	2.90	0.75	0.97	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.70	1.33	0.44	0.66	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	13.00	0.96	0.38	0.57	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.10	1.77	0.28	0.65	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.61	2.44	0.19	0.94	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	9.69	1.19	0.13	0.66	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.15	1.56	0.10	0.49	0.58	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.18	0.95	0.19	0.95	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.73	1.07	0.43	0.96	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.21	1.40	0.28	0.56	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.01	1.03	0.34	1.03	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.03	1.64	0.00	0.91	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.24	1.84	0.37	0.61	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	10.48	1.34	0.54	1.07	0.67	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.59	2.59	0.47	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	14.09	1.19	0.20	0.79	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	21.98	1.17	0.47	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.85	2.07	0.41	1.04	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	25.44	1.99	0.44	1.11	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	20.26	1.04	0.21	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.07	1.75	0.13	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.44	1.36	0.68	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	24.48	1.35	0.39	0.39	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.76	2.24	0.34	0.86	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.85	0.27	0.00	0.27	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	36.12	2.13	0.49	0.49	0.16	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.74	1.02	0.00	0.85	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	32.99	3.11	0.44	0.30	0.59	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	25.32	1.60	0.00	0.53	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	19.91	0.83	0.14	0.69	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.29	2.62	0.24	0.71	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	37.29	3.02	0.81	1.01	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.03	2.64	0.38	0.75	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	33.54	2.45	0.70	1.05	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.06	0.91	0.60	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	44.30	3.79	0.49	0.86	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.91	4.08	0.29	0.87	0.73	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	33.46	1.83	1.22	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.72	3.01	2.11	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	31.21	4.07	0.68	0.45	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	55.71	6.29	0.60	1.20	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	39.20	1.53	0.94	0.47	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	23.69	0.85	0.21	0.64	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	63.10	3.61	0.00	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	10.16	0.00	0.19	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	10.21	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	15.99	6.57	0.66	0.00	0.00	0.00
Sebocyte, donor1	11220-116B5	18.08	0.00	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	6.89	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	17.31	0.00	0.41	0.00	0.41	0.00
Sertoli Cells, donor1	11255-116F4	74.55	13.25	4.97	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	25.42	8.47	5.65	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	44.96	3.78	0.53	0.35	0.26	0.35
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.00	0.00	0.00	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	20.06	1.67	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	28.75	4.56	0.47	0.16	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	26.01	4.76	0.30	0.00	0.15	0.00
Skeletal Muscle Cells, donor6	11459-119B1	28.16	3.54	1.08	0.15	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	47.25	5.29	2.14	0.63	0.50	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	26.68	3.14	0.57	0.14	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	25.20	2.68	0.50	0.50	0.50	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.25	2.27	0.34	0.08	0.08	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	1.45	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	29.31	0.69	0.69	0.14	0.00	0.28
Skin - palm, donor1	10286-104F7	182.66	0.00	8.06	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.42	1.01	0.58	0.14	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	88.33	2.45	9.00	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	14.80	0.78	0.39	0.00	0.00	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	54.91	6.53	1.53	0.56	0.28	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	36.57	3.38	0.84	0.00	0.42	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	180.15	6.13	4.23	0.00	0.85	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	47.29	2.32	0.75	0.37	0.52	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	47.21	9.87	1.23	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	70.92	4.00	2.22	1.11	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	52.32	2.94	1.18	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	83.98	1.10	1.77	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.11	0.79	0.39	0.00	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	56.40	0.00	3.09	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	70.05	10.01	4.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	42.85	1.20	0.53	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	41.01	10.20	1.55	0.22	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	98.58	4.35	2.18	0.51	0.38	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	3.91	0.33	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.82	1.48	0.30	0.89	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	9.97	1.42	0.28	0.28	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.53	0.00	0.33	0.00	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.49	3.65	0.91	0.61	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	69.96	1.26	1.26	0.25	0.00	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	85.69	6.12	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.09	1.91	1.43	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.17	3.54	0.59	0.29	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	19.59	2.15	0.43	0.43	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.78	3.04	0.63	0.42	0.10	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	19.64	0.31	0.77	0.15	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	22.64	2.16	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.24	1.79	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.15	0.34	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.75	6.75	0.63	0.24	0.24	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	71.76	6.64	2.72	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	74.86	17.07	1.37	0.00	0.91	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	1.81	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	55.37	5.56	1.85	0.00	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.86	5.19	1.20	0.13	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	36.44	5.13	1.38	0.13	0.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	34.24	2.79	1.27	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	68.60	3.92	1.66	0.15	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	42.76	1.50	0.75	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	77.53	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	115.34	3.26	1.40	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	32.82	4.54	1.51	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	94.96	6.27	4.07	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.08	0.00	0.00	0.00	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	69.89	6.50	1.25	0.08	0.25	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	4.67	0.93	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	17.13	0.43	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.48	2.55	1.53	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.05	0.94	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	45.00	6.57	0.56	0.14	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	26.56	3.18	1.01	0.08	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.71	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	15.41	0.73	0.49	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	35.57	3.31	1.33	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	74.02	1.46	1.76	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	47.23	2.92	1.94	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	33.59	3.17	0.79	0.26	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	136.88	13.02	5.21	0.74	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	54.26	5.03	2.87	0.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	25.83	1.70	0.57	0.28	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	37.42	4.33	1.58	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	62.22	5.08	1.78	0.00	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	93.04	7.59	0.80	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	39.29	4.18	1.67	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	53.17	9.17	1.83	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	15.65	1.85	0.34	0.00	0.00	0.00
Synoviocyte, donor2	11368-117I9	116.50	22.80	3.69	0.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	70.82	12.51	2.68	0.45	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	0.00	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.57	0.00	0.23	0.23	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	21.86	2.08	0.93	0.22	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	0.00	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	15.46	0.57	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	389.25	44.90	7.63	1.72	0.49	0.25
Urethra, donor2	10319-105A4	109.70	0.00	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.84	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	6.41	0.00	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	3.44	0.00	0.00	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	29.87	1.78	0.89	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	669.12	44.49	12.46	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	687.64	44.32	8.58	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	260.12	43.12	2.74	0.00	0.68	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	376.71	38.22	5.17	0.69	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	414.85	38.35	3.49	0.00	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	604.96	39.57	12.49	1.04	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	596.56	34.88	12.85	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	277.52	34.69	1.83	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	29.98	1.48	0.99	0.49	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	23.76	0.88	0.88	0.88	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.47	3.07	0.00	0.00	0.84	0.28
achilles tendon, donor2	10292-104G4	101.26	4.13	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	123.91	10.71	0.25	0.51	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	107.03	5.34	0.70	1.86	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	83.10	7.12	0.95	0.83	0.71	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.89	3.27	0.54	1.36	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	17.15	3.37	0.84	1.41	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.09	1.06	0.63	0.21	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.77	4.08	0.27	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	82.40	7.05	1.76	1.76	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	52.68	5.31	1.23	0.82	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	104.84	9.71	0.78	1.16	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	5.70	0.74	0.18	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	0.00	7.80	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	57.40	5.81	0.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.95	0.52	0.00	1.04	0.26	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	6.43	0.88	0.00	0.00	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	57.17	2.79	1.86	2.32	1.39	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	49.76	2.88	0.00	0.82	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.75	1.23	0.00	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	105.40	4.69	1.28	1.71	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.37	5.46	0.00	1.82	1.52	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	124.20	10.59	1.20	0.96	1.44	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	3.79	0.45	0.45	0.22	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.35	1.33	0.33	2.00	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.68	0.75	1.13	0.75	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	37.51	2.18	0.87	2.18	1.31	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	63.73	1.87	1.87	5.62	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.03	0.47	0.00	0.47	1.18	0.00
adipose tissue, adult, pool1	10010-101C1	246.33	13.34	4.65	0.62	0.31	0.16
adipose, donor1	10184-103D4	210.52	104.38	2.93	23.46	5.28	2.35
adipose, donor2	10185-103D5	257.91	260.75	4.06	6.49	1.62	0.41
adipose, donor3	10186-103D6	290.80	81.69	3.27	12.80	3.81	1.63
adipose, donor4	10187-103D7	277.36	20.80	1.73	7.80	2.60	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	34.25	1.74	0.63	0.95	2.53	0.16
adrenal gland, adult, pool1	10081-102A9	189.16	3.64	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	68.17	5.34	0.93	1.20	0.80	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	136.49	26.44	1.79	1.43	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	102.71	10.67	1.16	0.46	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	95.01	5.07	0.34	0.34	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	97.51	9.43	2.36	0.59	0.00	0.29
amygdala - adult, donor10196	10167-103B5	29.64	3.56	0.00	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	86.38	10.54	1.62	1.62	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	221.42	19.69	6.46	6.13	1.29	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	271.21	35.65	2.67	0.00	0.13	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	46.33	7.06	1.10	0.44	0.66	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	190.74	12.69	1.67	1.34	1.67	0.33
aorta, adult, pool1	10052-101G7	155.53	7.85	2.55	0.59	0.59	0.00
appendix, adult	10189-103D9	110.61	9.70	2.33	0.78	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	74.63	5.85	0.69	3.78	0.69	0.34
artery, adult	10190-103E1	81.52	4.08	4.08	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	79.53	8.55	0.72	0.29	0.14	0.58
b cell line:RPMI1788	10427-106D4	68.85	5.35	1.19	0.74	0.89	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	105.98	8.60	1.66	0.00	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	41.68	4.37	0.60	0.60	0.00	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	33.31	4.85	0.50	1.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.11	3.36	0.00	1.12	0.00	1.12
bladder, adult, pool1	10011-101C2	294.20	15.32	3.91	0.65	0.87	0.11
blood, adult, pool1	10053-101G8	529.30	46.51	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	102.76	5.14	1.71	1.71	0.00	0.00
bone marrow, adult	10192-103E3	258.46	14.17	3.37	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	29.73	3.08	0.00	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	90.65	5.12	1.34	0.56	0.33	0.56
brain, fetal, pool1	10085-102B4	136.24	5.34	2.67	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	49.55	5.29	1.32	1.65	1.32	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	62.79	5.12	1.62	1.12	0.50	0.50
breast, adult, donor1	10080-102A8	142.69	6.31	2.53	1.26	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	15.37	1.40	0.00	0.00	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	43.91	6.18	0.62	0.31	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	65.61	8.75	3.22	2.07	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	41.15	5.57	0.48	1.94	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	18.34	7.99	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	18.16	0.33	0.88	0.33	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	107.11	22.18	2.22	1.58	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	57.76	8.52	1.06	13.31	5.32	0.27
caudate nucleus - adult, donor10196	10177-103C6	63.32	9.21	2.30	0.00	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	103.41	7.20	2.01	2.51	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	29.80	2.29	0.76	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	373.92	25.64	7.32	12.82	1.46	2.93
cerebellum - adult, donor10196	10173-103C2	189.36	0.00	5.83	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	216.93	12.81	2.78	1.71	0.64	0.00
cerebellum, adult, pool1	10083-102B2	100.72	5.86	0.34	1.03	2.07	0.00
cerebellum, newborn, donor10223	10357-105E6	280.64	6.64	5.81	18.27	2.49	1.66
cerebral meninges, adult	10188-103D8	66.06	8.57	2.77	0.50	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	55.55	1.46	0.73	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	24.87	2.44	0.14	0.58	0.43	0.00
cervical cancer cell line:ME-180	10553-107I4	109.70	10.44	0.66	0.00	0.17	0.00
cervix, adult, pool1	10013-101C4	210.19	12.18	3.88	0.52	0.63	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	85.14	11.43	1.39	0.14	0.14	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	2.61	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	88.61	10.81	0.75	0.12	0.12	0.12
choriocarcinoma cell line:SCH	10785-110H2	29.08	6.65	0.25	0.62	0.74	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	15.42	2.37	0.47	0.24	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	195.74	19.09	2.28	0.28	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	53.59	5.67	1.59	0.00	0.30	0.10
chorionic membrane cells, donor3	12240-129G8	481.90	48.90	8.79	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	30.29	10.10	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.78	2.31	0.19	0.58	0.19	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	13.30	0.00	0.00	1.69	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	66.00	5.65	0.77	2.82	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	78.13	7.98	2.18	1.94	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	64.34	6.31	1.02	2.24	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	140.75	8.54	2.06	0.88	1.47	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	36.75	0.52	1.56	0.00	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	61.49	12.80	1.37	0.23	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	91.61	14.23	1.74	0.35	0.35	0.69
colon carcinoma cell line:CACO-2	10513-107D9	49.79	4.58	0.37	0.55	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	69.93	3.80	0.76	0.00	1.52	0.00
colon, adult, donor1	10082-102B1	63.07	0.00	2.38	1.19	1.19	0.00
colon, adult, pool1	10014-101C5	144.18	9.87	1.88	0.35	0.24	0.00
colon, fetal, donor1	10070-101I7	241.63	30.90	3.09	0.00	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	55.00	0.00	9.17	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	108.36	4.67	0.85	2.55	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	21.89	1.66	0.30	0.15	0.45	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	20.87	2.12	0.14	0.00	0.42	0.00
corpus callosum, adult, pool1	10042-101F6	142.18	5.64	2.43	1.77	0.88	0.22
cruciate ligament, donor2	10295-104G7	199.38	5.67	4.86	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	130.02	6.42	4.01	0.00	0.80	0.00
diencephalon, adult	10193-103E4	45.84	4.56	0.96	0.72	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	84.50	8.73	1.15	1.38	0.92	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.26	3.59	0.26	0.26	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	83.05	7.46	2.65	1.93	0.48	0.00
ductus deferens, adult	10196-103E7	69.27	7.97	2.49	2.99	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	142.58	11.52	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	141.24	23.54	3.68	0.74	0.74	0.00
dura mater, adult, donor1	10041-101F5	240.58	8.92	4.54	0.91	0.50	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	58.41	4.66	0.44	2.00	1.11	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	10.89	1.72	0.29	0.72	0.29	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	55.50	0.62	0.62	0.00	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	53.58	3.63	1.51	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.04	2.16	0.31	0.93	1.23	0.31
embryonic pancreas cell line:2C6	10603-108E9	42.03	5.25	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	25.47	2.35	0.34	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	75.76	7.25	1.81	0.91	0.54	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	18.17	3.70	0.80	0.16	0.32	0.16
epidermoid carcinoma cell line:A431	10426-106D3	27.12	2.45	0.44	0.22	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	26.51	2.53	0.44	0.11	0.11	0.11
epididymis, adult	10197-103E8	105.70	9.42	2.30	0.84	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	86.93	7.45	2.13	1.06	0.71	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	49.94	5.11	1.57	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	36.30	4.72	0.39	1.31	0.26	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	68.11	9.15	1.08	3.15	0.49	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	32.71	4.71	0.67	1.12	0.11	0.00
esophagus, adult, pool1	10015-101C6	172.33	9.98	4.25	0.42	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	14.90	1.13	0.25	0.00	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	149.70	9.66	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	58.92	4.21	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	47.62	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	94.01	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	116.59	1.46	1.46	2.91	0.00	2.91
eye, fetal, donor1	10054-101G9	324.91	38.90	8.90	3.31	3.56	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	22.05	2.18	0.38	0.38	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.30	3.56	0.47	1.66	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	85.76	4.69	1.88	0.47	0.75	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	205.07	18.62	3.00	1.20	0.30	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	138.34	8.05	1.55	0.27	0.27	0.09
gall bladder, adult	10198-103E9	104.54	8.69	1.69	0.00	0.72	0.00
gamma delta positive T cells, donor1	11937-126A2	419.28	24.70	3.76	2.15	3.22	1.07
gamma delta positive T cells, donor2	11938-126A3	346.97	31.37	5.60	2.24	2.24	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	46.05	5.70	1.27	1.06	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	17.21	1.74	0.00	1.16	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	33.28	4.75	0.33	0.98	0.49	0.49
gastric cancer cell line:GSS	10560-108A2	36.61	5.49	1.83	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	51.63	4.11	0.69	2.28	0.46	0.69
giant cell carcinoma cell line:LU65	10487-107B1	50.49	6.20	0.23	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	48.01	4.48	0.98	0.14	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	33.67	1.50	1.00	1.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	27.02	2.43	0.74	1.16	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	38.62	1.97	0.70	0.56	0.56	0.00
glioblastoma cell line:T98G	10485-107A8	110.48	10.60	2.10	0.66	0.44	0.11
glioma cell line:GI-1	10413-106B8	47.74	1.46	1.17	0.59	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	56.13	5.10	1.46	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	169.16	14.89	1.22	1.95	0.49	0.49
globus pallidus, adult, donor10258	10367-105F7	56.14	5.48	0.00	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	173.20	17.05	6.40	3.73	1.07	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	4.89	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	94.08	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	44.16	4.48	0.00	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	55.09	5.51	0.00	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	44.81	7.32	0.91	1.83	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	39.93	2.58	0.64	1.93	0.00	0.64
hIPS, biol_rep1	14380-156B6	83.36	4.31	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	38.41	2.74	0.00	3.43	0.00	0.00
hIPS, biol_rep3	14382-156B8	38.62	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	124.42	14.65	2.01	1.72	0.86	0.29
heart - mitral valve, adult	10205-103F7	161.74	15.55	2.39	0.60	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	48.90	3.66	1.31	0.00	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	249.79	33.31	7.49	0.00	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	41.02	3.47	0.41	1.02	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	43.43	0.43	1.28	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	87.85	7.59	0.46	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	157.72	7.39	2.46	0.72	1.13	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	73.12	4.01	1.54	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	0.00	0.00	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	16.57	1.33	0.11	0.77	0.44	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	21.00	1.58	0.36	0.85	0.73	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	20.01	2.32	0.40	0.71	0.40	0.20
hepatoma cell line:Li-7	10484-107A7	50.38	5.23	0.33	0.44	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	36.78	1.71	0.40	1.81	0.50	0.40
hippocampus - adult, donor10196	10169-103B7	42.58	5.68	2.84	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	99.60	10.00	1.84	1.84	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	49.30	4.98	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	194.57	15.16	3.17	4.58	0.70	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	177.00	21.97	0.61	12.21	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	92.29	12.37	1.18	4.32	1.77	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	105.62	13.71	1.78	6.86	1.02	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	91.35	11.84	1.13	5.07	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	121.36	26.08	1.29	5.42	1.81	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	117.68	20.12	1.14	6.07	1.52	3.42
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	317.06	47.59	5.26	30.36	6.71	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	375.49	56.01	2.80	21.33	4.09	4.95
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	274.85	36.29	3.75	32.11	5.84	5.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	356.14	42.39	4.03	14.21	1.66	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	343.13	55.93	4.18	15.43	2.09	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	383.78	49.15	9.43	8.75	4.71	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	75.89	22.69	0.63	2.35	0.31	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	88.92	19.65	0.98	2.95	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	128.29	39.27	4.36	14.84	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	90.68	43.91	1.72	4.77	2.48	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	74.13	34.45	1.31	4.80	1.31	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	121.94	46.98	2.00	10.00	2.00	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	433.68	157.12	4.90	14.69	2.26	1.70
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	477.00	215.54	6.37	17.28	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	366.80	191.70	7.52	19.11	3.76	2.51
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	252.79	129.50	3.27	15.51	2.45	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	274.92	114.38	3.77	10.74	2.61	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	216.42	101.04	5.38	20.03	2.09	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	98.10	11.82	1.29	3.51	0.92	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	86.16	9.41	2.00	2.28	0.57	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	118.41	12.66	2.86	6.53	1.63	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	112.67	11.62	2.46	5.63	1.41	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	79.50	13.62	1.58	0.95	0.00	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	88.06	15.43	2.42	3.03	2.12	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	261.15	27.92	1.55	11.38	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	306.18	41.84	3.98	15.94	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	243.96	26.17	5.90	17.44	3.59	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	252.32	32.47	5.88	12.27	1.28	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	306.68	41.65	3.79	14.39	2.27	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	217.77	37.30	4.37	15.46	3.70	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	101.19	13.04	2.66	3.62	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	130.13	12.48	1.34	7.58	0.89	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	118.05	11.22	1.46	3.41	1.46	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	99.33	11.61	0.92	6.11	0.61	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	686.43	91.09	9.76	55.31	9.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	150.58	25.81	1.65	9.60	3.31	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	330.57	37.22	5.47	21.89	3.28	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	359.35	50.30	3.98	20.99	5.07	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	291.46	45.55	4.27	22.78	4.27	2.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	297.15	38.19	4.77	16.71	2.39	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	502.43	37.65	8.13	22.75	3.93	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	224.68	40.41	4.31	17.51	2.16	2.96
immature langerhans cells, donor1	11904-125F5	174.59	12.35	6.30	0.48	0.00	0.00
immature langerhans cells, donor2	11905-125F6	108.52	6.34	2.38	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	76.46	3.50	2.08	0.47	0.47	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	26.99	3.25	0.65	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	132.57	10.21	2.90	1.00	0.40	0.40
kidney, fetal, pool1	10045-101F9	233.57	4.10	4.81	1.91	0.71	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	133.22	10.23	2.41	0.57	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.38	2.35	0.41	0.28	0.14	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.83	4.22	0.73	0.37	0.00	0.00
left atrium, adult, donor1	10079-102A7	57.75	2.18	1.63	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	56.63	3.54	0.00	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	29.55	1.92	0.00	0.27	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	30.90	5.75	1.08	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	13.04	4.89	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	41.52	5.83	2.19	0.49	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	38.69	1.05	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	80.28	6.26	0.83	2.72	0.71	0.35
liposarcoma cell line:KMLS-1	10782-110G8	34.99	2.34	0.31	0.31	0.62	0.16
liposarcoma cell line:SW 872	10726-110A6	230.40	17.67	4.14	4.02	2.44	0.85
liver, adult, pool1	10018-101C9	109.55	4.38	3.08	0.00	0.00	0.32
liver, fetal, pool1	10086-102B5	47.04	1.88	2.82	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	60.08	5.25	1.17	0.73	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	115.90	13.10	3.32	2.40	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	42.60	4.51	1.69	0.85	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	234.28	17.25	4.63	11.36	2.94	2.52
lung adenocarcinoma cell line:A549	10499-107C4	29.20	2.91	0.55	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	57.22	1.38	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.85	3.95	1.71	0.13	1.32	0.26
lung, adult, pool1	10019-101D1	259.88	12.88	4.73	0.47	0.83	0.12
lung, fetal, donor1	10068-101I5	1139.06	38.53	21.12	1.43	1.14	0.29
lung, right lower lobe, adult, donor1	10075-102A3	252.48	21.08	5.96	2.29	0.92	1.37
lymph node, adult, donor1	10077-102A5	76.68	4.26	3.31	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	37.70	3.51	0.66	0.66	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	26.56	0.30	0.15	0.75	0.15	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	118.93	9.34	0.85	5.10	2.55	0.00
mature adipocyte, donor1	12231-129F8	146.07	5.33	2.22	0.00	0.44	0.44
mature adipocyte, donor2	12232-129F9	132.82	4.77	2.28	1.25	1.04	0.00
mature adipocyte, donor3	12233-129G1	123.27	3.79	2.61	0.24	0.24	0.47
mature adipocyte, donor4	12234-129G2	132.92	5.79	2.11	0.79	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	99.35	3.34	0.48	0.95	1.91	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	41.74	2.26	2.26	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	116.23	9.20	2.02	1.10	0.55	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	48.29	3.81	1.27	0.00	0.32	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	348.87	28.57	11.09	31.13	4.69	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	42.86	2.53	0.84	0.34	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	96.14	6.37	0.85	1.06	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	71.77	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	251.61	16.87	5.03	9.33	1.79	1.79
medulla oblongata - adult, donor10196	10174-103C3	136.29	15.58	4.54	1.95	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	127.56	8.82	1.24	2.79	0.31	0.93
medulla oblongata, adult, pool1	10038-101F2	122.93	5.39	3.35	0.98	0.57	0.08
medulla oblongata, newborn, donor10223	10361-105F1	114.22	16.66	2.78	2.43	1.04	2.08
medulloblastoma cell line:D283 Med	10838-111E1	94.54	6.64	1.77	1.99	1.77	0.00
medulloblastoma cell line:ONS-76	10759-110E3	30.94	1.71	0.24	0.12	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	11.93	0.72	0.14	0.00	0.00	0.00
melanoma cell line:G-361	10465-106H6	9.77	0.81	0.00	0.00	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	26.77	5.07	0.18	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	103.98	6.17	0.88	3.52	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	41.73	4.41	0.52	3.37	1.81	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	43.73	3.99	1.38	0.15	0.15	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	44.72	2.36	1.09	0.18	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	47.62	2.07	0.83	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	84.00	8.29	2.81	0.42	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	60.85	3.27	0.77	1.16	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	82.60	10.41	2.78	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	86.68	9.61	2.40	0.00	0.00	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	101.90	9.20	3.91	0.23	0.23	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	56.37	6.90	2.25	0.13	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	39.30	2.97	0.14	0.00	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	28.88	1.71	0.43	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	25.36	1.98	0.99	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	23.94	2.49	0.42	0.00	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	64.58	5.59	1.75	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.58	2.04	0.61	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	15.82	3.59	0.72	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	48.31	5.48	1.66	0.10	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.54	2.74	0.00	0.00	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	79.30	5.03	1.68	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	52.30	3.14	1.34	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	61.62	7.97	1.58	0.09	0.09	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.24	1.10	3.68	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	11.73	3.43	0.57	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.94	10.53	0.84	2.11	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	41.56	3.20	2.28	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	54.23	10.49	2.56	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	52.09	7.07	1.05	0.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	50.53	10.47	1.23	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	60.72	8.94	1.88	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	56.18	5.42	1.69	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	62.48	7.07	2.75	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	54.22	7.88	3.24	0.00	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	82.20	10.09	4.90	0.29	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	68.94	5.58	3.35	0.67	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	74.99	9.85	1.68	0.48	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	110.00	5.87	4.40	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	61.76	5.71	1.68	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	62.63	6.96	3.28	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	53.27	7.30	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	71.09	8.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	59.76	8.12	2.27	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	50.92	8.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	59.70	5.33	1.60	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	28.62	4.09	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	33.43	5.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	48.27	6.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	5.96	2.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	28.46	3.56	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	3.66	2.44	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	6.33	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	34.49	2.76	1.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	6.45	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	28.93	2.85	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	26.22	2.38	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	2.95	1.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.51	3.43	0.00	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	1.34	1.34	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	2.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	10.27	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.70	7.92	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	3.36	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.80	4.45	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	2.01	0.00	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	4.52	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	1.65	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.72	2.78	0.79	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	28.88	4.22	0.97	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	23.43	7.13	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	77.37	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	178.83	18.66	3.07	1.18	0.47	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	89.66	10.66	0.70	1.85	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	9.66	0.41	0.21	0.21	0.21	0.21
mesothelioma cell line:Mero-25	10850-111F4	49.25	4.99	0.91	1.13	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	18.34	2.69	0.00	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	19.71	2.66	0.44	0.44	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	68.07	11.56	1.84	0.53	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	5.28	0.51	0.00	0.17	0.17	0.17
mesothelioma cell line:Mero-84	10855-111F9	6.32	0.51	0.25	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	11.59	1.45	0.41	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	12.26	2.48	0.00	0.99	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	14.48	3.44	0.36	1.45	0.00	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	102.15	13.32	2.73	4.10	0.85	0.34
mesothelioma cell line:NCI-H28	10845-111E8	162.09	22.39	1.78	12.72	4.07	0.51
mesothelioma cell line:No36	10857-111G2	5.87	0.33	1.30	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	32.24	2.17	1.08	0.81	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	383.08	22.45	10.94	1.92	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	127.37	5.74	2.20	1.47	1.10	0.49
migratory langerhans cells, donor3	11903-125F4	150.40	9.69	3.05	1.44	0.54	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	69.54	20.24	0.65	0.00	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	51.29	9.75	0.85	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.16	0.69	0.46	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	54.04	5.71	0.00	1.33	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	29.57	1.29	0.18	0.74	0.55	0.18
myeloma cell line:PCM6	10474-106I6	31.23	3.36	0.00	0.00	0.00	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	2.54	0.00	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	44.72	3.73	0.00	0.98	0.20	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.72	2.01	0.56	0.11	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	22.06	2.21	0.44	0.22	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	88.87	3.86	3.31	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	118.94	13.11	0.46	6.21	2.99	0.00
neuroblastoma cell line:NB-1	10539-107G8	62.30	3.93	2.06	0.75	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	37.96	5.90	0.21	1.27	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	110.69	11.18	0.75	4.66	2.05	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	75.67	6.17	0.71	2.14	1.66	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	105.01	16.63	2.06	3.33	1.27	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	6.24	0.60	0.20	0.20	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	39.42	3.18	3.18	0.00	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	43.12	4.26	0.80	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	89.63	4.23	0.68	1.18	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	82.45	1.60	2.40	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	143.31	16.99	2.56	0.32	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	51.76	13.93	1.31	0.53	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	71.90	3.47	1.12	0.47	0.47	0.19
occipital cortex - adult, donor10196	10172-103C1	55.63	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	148.40	13.95	2.42	1.07	0.54	0.81
occipital cortex, newborn, donor10223	10355-105E4	226.37	10.92	8.37	6.91	0.73	4.00
occipital lobe, adult, donor1	10076-102A4	51.43	4.72	1.05	0.00	0.79	0.26
occipital lobe, fetal, donor1	10073-102A1	240.30	11.16	4.72	3.43	2.57	0.00
occipital pole, adult, pool1	10036-101E9	47.07	1.34	1.26	0.47	0.16	0.00
olfactory region, adult	10195-103E6	42.99	5.16	1.72	0.00	0.38	0.00
optic nerve, donor1	10277-104E7	304.16	8.00	2.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	27.00	1.48	0.34	1.03	0.80	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	33.93	5.63	0.55	0.27	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	84.49	6.10	1.35	1.02	0.34	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	18.71	1.73	0.35	0.12	0.00	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	31.75	2.94	0.29	0.29	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	67.27	3.74	2.80	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	51.11	1.70	0.64	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	368.71	16.16	5.77	0.87	0.70	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.78	3.67	0.00	0.37	0.37	0.00
pancreas, adult, donor1	10049-101G4	71.49	2.82	2.82	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.77	2.52	0.00	0.28	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	73.08	8.86	0.85	0.68	0.85	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.98	1.99	1.32	0.17	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	68.18	3.84	1.83	0.37	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	100.56	2.20	2.20	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	71.48	4.70	0.94	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	130.83	9.12	2.00	2.57	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	73.05	3.00	1.06	0.44	0.35	0.35
parietal lobe, fetal, donor1	10072-101I9	264.76	12.61	2.91	5.82	5.82	1.94
parietal lobe, newborn, donor10223	10356-105E5	249.36	23.55	10.47	11.96	1.87	1.87
parotid gland, adult	10199-103F1	81.40	10.48	3.08	1.23	0.62	0.00
penis, adult	10200-103F2	99.37	8.06	2.15	1.07	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	58.20	5.02	1.30	5.39	2.23	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	129.38	15.44	3.35	0.29	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	96.11	4.52	1.94	9.03	5.81	0.65
pineal gland, adult, donor10252	10160-103A7	252.28	17.17	2.37	22.50	7.11	0.59
pineal gland, adult, donor10258	10377-105G8	90.30	6.27	3.76	5.64	5.02	0.00
pituitary gland - adult, donor10196	10180-103C9	159.86	6.07	3.04	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	211.60	8.86	3.65	3.65	3.65	0.52
pituitary gland, adult, donor10258	10378-105G9	69.80	9.36	2.55	2.55	1.70	1.70
placenta, adult, pool1	10021-101D3	273.38	13.98	5.59	0.75	0.32	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	69.39	5.03	0.66	0.93	0.53	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	248.24	19.45	2.65	1.09	0.00	0.00
pons, adult, pool1	10033-101E6	82.97	5.42	2.07	0.26	0.43	0.00
postcentral gyrus, adult, pool1	10032-101E5	63.81	2.18	1.83	0.87	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	11.02	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	132.70	22.14	2.04	0.44	0.73	0.58
prostate cancer cell line:PC-3	10439-106E7	68.06	4.17	0.73	2.18	0.54	0.00
prostate, adult, pool1	10022-101D4	183.20	9.61	3.54	0.36	0.63	0.00
putamen, adult, donor10196	10176-103C5	33.76	3.78	1.18	0.24	0.00	0.00
putamen, adult, donor10252	10152-102I8	92.15	1.96	1.96	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	53.55	3.28	2.19	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	27.30	1.45	0.97	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	536.01	44.23	9.00	26.24	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	32.29	1.45	0.00	0.87	0.00	0.00
rectum, fetal, donor1	10067-101I4	280.98	33.38	1.39	1.39	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	405.76	33.28	4.66	3.82	0.85	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	586.52	87.40	5.38	0.41	0.41	1.24
retina, adult, pool1	10030-101E3	153.47	4.97	3.48	1.19	0.99	0.50
retinoblastoma cell line:Y79	10475-106I7	90.15	8.05	1.04	1.04	1.04	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	45.37	4.43	0.37	0.49	0.74	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	98.14	6.47	1.12	1.41	1.41	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	38.65	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	18.78	1.62	0.81	0.49	0.16	0.00
salivary acinar cells, donor2	11772-123I8	74.63	4.41	2.07	0.55	0.55	0.14
salivary acinar cells, donor3	11773-123I9	76.80	2.65	3.31	0.66	1.32	0.00
salivary gland, adult, pool1	10093-102C3	144.13	5.72	3.43	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.34	4.05	0.67	0.17	0.17	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	41.50	2.35	0.12	0.24	0.35	0.35
seminal vesicle, adult	10201-103F3	131.74	13.76	1.59	1.06	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	279.12	37.90	8.50	0.73	0.49	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	68.19	9.31	0.75	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	54.19	15.05	3.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	92.82	20.01	0.81	0.54	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	27.30	2.76	0.22	0.55	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	58.71	7.35	0.77	0.52	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	375.95	21.28	6.38	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	248.27	11.87	5.16	0.24	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	73.37	4.02	3.02	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	244.27	6.79	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	474.68	41.66	8.21	4.42	1.89	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	50.70	4.00	0.00	2.33	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	95.51	9.77	1.26	6.30	1.26	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	79.22	10.60	2.12	0.96	1.54	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	88.35	8.24	0.49	0.49	0.82	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	96.19	13.83	1.29	3.54	2.09	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	50.56	3.92	0.87	0.44	0.00	0.00
small intestine, adult, pool1	10024-101D6	75.85	7.05	1.19	0.24	0.12	0.00
small intestine, fetal, donor1	10064-101I1	103.68	10.56	2.70	0.74	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	31.29	4.10	0.51	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	97.18	6.46	2.58	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	73.71	1.88	1.07	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	119.29	5.96	2.52	2.98	1.38	0.23
spinal cord, adult, donor10252	10159-103A6	190.43	9.46	4.34	2.37	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	106.54	12.45	4.84	4.15	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	101.84	6.10	1.83	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	184.60	9.18	2.76	6.43	1.38	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	45.11	1.79	1.05	0.15	0.30	0.00
spleen, adult, pool1	10025-101D7	104.74	6.94	1.98	0.33	0.33	0.00
spleen, fetal, pool1	10044-101F8	176.79	2.78	3.97	1.59	0.87	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	32.19	2.48	0.41	0.72	0.31	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	102.91	8.54	1.52	0.57	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	52.77	7.34	0.70	0.70	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	45.74	5.08	0.00	0.00	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	165.12	21.95	2.25	1.35	0.90	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	4.66	0.42	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	19.04	1.69	0.42	0.00	0.85	0.00
stomach, fetal, donor1	10062-101H8	153.79	6.41	6.41	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	66.65	5.13	1.71	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	325.64	379.92	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	126.70	15.79	1.25	3.32	0.62	0.00
substantia nigra, adult, donor10258	10371-105G2	43.45	1.55	4.14	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	157.57	14.84	4.95	4.24	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	26.14	2.98	0.46	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	49.51	0.59	1.70	0.34	0.68	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	206.56	7.83	4.27	6.41	2.85	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	121.31	9.67	1.32	4.40	2.64	0.00
tenocyte, donor1	11763-123H8	53.76	11.17	1.40	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	69.82	19.46	3.43	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	55.97	16.68	1.11	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	95.18	13.43	1.36	1.36	1.02	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	24.20	2.31	0.31	1.23	0.77	0.15
teratocarcinoma cell line:PA-1	10807-111A6	29.60	2.48	0.31	0.93	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	25.14	2.92	0.25	0.89	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.89	8.32	0.00	3.03	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.12	1.96	0.22	1.53	0.55	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	93.80	9.12	1.30	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	142.59	9.23	3.76	1.83	2.15	1.29
testis, adult, pool2	10096-102C6	47.82	6.77	1.35	4.51	4.06	1.80
thalamus - adult, donor10196	10168-103B6	91.63	11.04	2.21	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	138.62	12.35	2.34	2.97	0.47	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	92.38	7.70	1.54	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.62	1.98	0.82	1.65	0.66	0.49
thalamus, newborn, donor10223	10366-105F6	352.10	25.31	5.75	31.64	3.45	1.73
throat, adult	10209-103G2	129.58	13.23	4.24	0.75	0.00	0.00
throat, fetal, donor1	10061-101H7	302.88	24.99	7.01	2.13	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	30.41	2.58	0.99	0.40	0.20	0.60
thymus, adult, pool1	10027-101D9	115.22	3.28	1.59	0.30	1.09	0.00
thymus, fetal, pool1	10043-101F7	353.07	7.90	6.23	4.68	2.29	1.35
thyroid carcinoma cell line:KHM-5M	10776-110G2	77.25	3.99	1.60	0.40	0.27	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	114.27	11.45	2.10	3.07	0.70	0.56
thyroid, adult, pool1	10028-101E1	439.41	28.83	9.14	3.08	0.65	0.65
thyroid, fetal, donor1	10060-101H6	255.49	13.97	8.70	2.64	1.32	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	203.25	12.32	9.24	0.00	6.16	0.00
tongue, adult	10203-103F5	102.33	7.91	2.56	0.00	0.00	0.23
tongue, fetal, donor1	10059-101H5	219.12	24.04	4.34	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	197.45	6.51	3.41	0.50	0.80	0.20
trachea, adult, pool1	10029-101E2	303.47	15.79	5.15	0.16	0.33	0.25
trachea, fetal, donor1	10058-101H4	348.53	47.32	8.85	1.15	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	28.70	5.31	1.06	0.00	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	113.47	5.37	1.01	0.71	0.51	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	186.61	25.54	2.82	2.82	2.51	0.16
tridermal teratoma cell line:HGRT	10694-109G1	34.25	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	100.90	8.38	1.52	0.85	0.93	0.17
umbilical cord, fetal, donor1	10057-101H3	112.67	12.52	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	256.28	11.26	5.46	0.34	0.17	0.00
uterus, fetal, donor1	10055-101H1	376.78	30.72	4.10	1.54	1.54	0.00
vagina, adult	10204-103F6	86.59	3.88	0.65	3.23	1.94	0.00
vein, adult	10191-103E2	93.60	4.60	1.53	0.66	0.22	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	15.76	1.87	0.27	0.00	0.27	0.00